🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Amod A. Sarnaik

Moffitt Cancer Center

ORCID: 0000-0002-2337-5898
MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Data from Single-Cell Characterization of the Immune Microenvironment of Melanoma Brain and Leptomeningeal Metastases

(2023)10.1158/1078-0432.c.6530586.v1
Top 100%
0DataRank
Top 100%0 citations

Zhihua Chen, Manali Phadke, Jiannong Li, Xiaoqing Yu, Clayton Wyatt +15 more

Papers

Driven by 15 papers — median percentile 0. Top paper: “Combination Nivolumab, CD137 Agonism, and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic Melanoma”.

Combination Nivolumab, CD137 Agonism, and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic Melanoma

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-2103
N/A
0.571DataRank · unranked
44 citations

John E. Mullinax, Cheryl A. Cox, Amy M. Hall, Matthew Beatty, Jamie Blauvelt +18 more

Genomic Correlates of Outcome in Tumor-Infiltrating Lymphocyte Therapy for Metastatic Melanoma

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-1060
N/A
0.434DataRank · unranked
17 citations

Yuzhong Jeff Meng, Marie‐Andrée Forget, Tatiana V. Karpinets, Katarzyna Tomczak, Chip Stewart +22 more

Dichotomous Nitric Oxide–Dependent Post-Translational Modifications of STAT1 Are Associated with Ipilimumab Benefits in Melanoma

Cancers(2023)10.3390/cancers15061755
N/A
0.292DataRank · unranked
6 citations

James Sun, Young‐Chul Kim, Junmin Whiting, Amod A. Sarnaik, José R. Conejo-García +5 more

Neoantigen-specific CD4+ tumor-infiltrating lymphocytes are potent effectors identified within adoptive cell therapy products for metastatic melanoma patients

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2023-007288
N/A
0DataRank · unranked
36 citations

Jamie K. Teer, Xiaoqing Yu, Holly Branthoover, Sebastian Snedal, Madeline Rodríguez-Valentín +20 more

Data from Single-Cell Characterization of the Immune Microenvironment of Melanoma Brain and Leptomeningeal Metastases

(2023)10.1158/1078-0432.c.6530586.v1
Top 100%
0DataRank
Top 100%0 citations

Zhihua Chen, Manali Phadke, Jiannong Li, Xiaoqing Yu, Clayton Wyatt +15 more

Supplementary Table 5 from Single-Cell Characterization of the Immune Microenvironment of Melanoma Brain and Leptomeningeal Metastases

(2023)10.1158/1078-0432.22480995
Top 100%
0DataRank
Top 100%0 citations

Zhihua Chen, Manali Phadke, Jiannong Li, Xiaoqing Yu, Clayton Wyatt +15 more

Data from HDAC Inhibition Upregulates PD-1 Ligands in Melanoma and Augments Immunotherapy with PD-1 Blockade

(2023)10.1158/2326-6066.c.6548923.v1
N/A
0DataRank · unranked
0 citations

Andressa L. Sodré, Alejandro Villagra, Amod A. Sarnaik, Eduardo M. Sotomayor, Jeffrey S. Weber +1 more

Expert consensus guidelines on management and best practices for tumor-infiltrating lymphocyte cell therapy

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2023-008735
N/A
0DataRank · unranked
79 citations

Omid Hamid, Krishna V. Komanduri, Rodabe N. Amaria, Marcus O. Butler, John B.A.G. Haanen +6 more

Tumor-infiltrating lymphocytes: A new hope

Cancer Cell(2024)10.1016/j.ccell.2024.06.015
N/A
0DataRank · unranked
57 citations

Patrick Hwu, James J. Mulé, Shari Pilon‐Thomas, Amod A. Sarnaik

Preexisting Skin-Resident CD8 and γδ T-cell Circuits Mediate Immune Response in Merkel Cell Carcinoma and Predict Immunotherapy Efficacy

Cancer Discovery(2024)10.1158/2159-8290.cd-23-0798
N/A
0DataRank · unranked
25 citations

Yue Zhang, Oscar E. Ospina, Matt D. Nichols, Victoria A. Chu, Álvaro de Mingo Pulido +31 more

Neoadjuvant Intratumoral Plasmid IL-12 Electro-Gene-Transfer and Nivolumab in Patients with Operable, Locoregionally Advanced Melanoma

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-2768
N/A
0DataRank · unranked
11 citations

Zeynep Eroglu, Islam Eljilany, Jonathan S. Zager, R. Gonzalez, Amod A. Sarnaik +13 more

Single-Cell Characterization of the Immune Microenvironment of Melanoma Brain and Leptomeningeal Metastases

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-1694
N/A
0DataRank · unranked
166 citations

Zhihua Chen, Manali Phadke, Jiannong Li, Xiaoqing Yu, Clayton Wyatt +15 more

First-in-Human Stage III/IV Melanoma Clinical Trial of Immune Priming Agent IFx-Hu2.0

Molecular Cancer Therapeutics(2024)10.1158/1535-7163.mct-23-0652
N/A
0DataRank · unranked
9 citations

Michael J. Shamblott, Andrew S. Brohl, Amod A. Sarnaik, Zeynep Eroglu, Nikhil I. Khushalani +13 more

Expansion of tumor-infiltrating lymphocytes (TIL) from penile cancer patients

International Immunopharmacology(2021)10.1016/j.intimp.2021.107481
N/A
0DataRank · unranked
33 citations

MacLean Hall, Brittany Bunch, Holly Branthoover, Zachary Sannasardo, Amy Mackay +6 more

IFx-Hu2.0 phase I first in human study for unresectable melanoma for an intralesional “in-situ vaccine” approach.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.e21542
N/A
0DataRank · unranked
6 citations

Michael J. Shamblott, Andrew S. Brohl, Amod A. Sarnaik, Zeynep Eroglu, Nikhil I. Khushalani +7 more